Skip to content
healthcare.dev

Sandostatin

NDC 0078-0180, octreotide acetate, injection, solution, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0180
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA019667
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0180 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OCTREOTIDE ACETATE50 ug/mL

Pharmacologic classes

Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]

Package NDCNDC-11Package
0078-0180-010007801800110 AMPULE in 1 PACKAGE (0078-0180-01) / 1 mL in 1 AMPULE (0078-0180-61)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4e2c9856-1836-49f0-9472-4dbeeb408f39
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0078-0180

Use it

Look up 0078-0180 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0180 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0180. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.